Advertisement
UK markets close in 3 hours 13 minutes

  • FTSE 100

    8,337.61
    +23.94 (+0.29%)
     

  • FTSE 250

    20,407.58
    -5.50 (-0.03%)
     

  • AIM

    777.59
    +1.17 (+0.15%)
     

  • GBP/EUR

    1.1615
    -0.0009 (-0.08%)
     

  • GBP/USD

    1.2478
    -0.0032 (-0.25%)
     

  • Bitcoin GBP

    50,000.04
    -989.52 (-1.94%)
     

  • CMC Crypto 200

    1,320.67
    +26.00 (+2.01%)
     

  • S&P 500

    5,187.70
    +6.96 (+0.13%)
     

  • DOW

    38,884.26
    +31.99 (+0.08%)
     

  • CRUDE OIL

    77.37
    -1.01 (-1.29%)
     

  • GOLD FUTURES

    2,324.90
    +0.70 (+0.03%)
     

  • NIKKEI 225

    38,202.37
    -632.73 (-1.63%)
     

  • HANG SENG

    18,313.86
    -165.51 (-0.90%)
     

  • DAX

    18,488.14
    +58.09 (+0.32%)
     

  • CAC 40

    8,143.42
    +67.74 (+0.84%)
     
Money:

How to make a tax-free income

Tips for making money that won't be taxed

Progenics: 1Q Earnings Snapshot

Progenics: 1Q Earnings Snapshot

Associated Press

NEW YORK (AP) _ Progenics Pharmaceuticals Inc. (PGNX) on Thursday reported a loss of $18.7 million in its first quarter.

The New York-based company said it had a loss of 22 cents per share.

The biopharmaceutical company posted revenue of $4.3 million in the period.

Progenics shares have increased 24% since the beginning of the year. The stock has dropped 25% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PGNX at https://www.zacks.com/ap/PGNX